NYSE: ABT
Abbott Laboratories Stock

Overview

Forecast Earnings Dividend Ownership

ABT Price

$112.84

Fair Value Price

N/A

Market Cap

$199.79B

52 Week Low

$61.61

52 Week High

$115.14

P/E

59.39x

P/B

6.32x

P/S

5.99x

PEG

1.57x

Dividend Yield

1.24%

Revenue

$32.22B

Earnings

$3.38B

Gross Margin

56.7%

Operating Margin

13.7%

Profit Margin

10.5%

Debt to Equity

1.19

Operating Cash Flow

$7B

Beta

0.92

Next Earnings

Jan 27, 2021

Ex-Dividend

Jan 14, 2021

Next Dividend

Feb 16, 2021

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

ABT ($112.84) is trading below its intrinsic value of $252.96, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"

Valuation

ABT is poor value based on its earnings relative to its share price (59.39x), compared to the US market average (27.75x)

Valuation

ABT is poor value based on its earnings relative to its share price (59.39x), compared to the US Medical Devices industry average (55.45x)

Valuation

ABT News

Valuation

ABT price to earnings (PE)

For valuing profitable companies with steady earnings

Company

59.39x

Industry

55.45x

Market

27.75x

ABT is poor value based on its earnings relative to its share price (59.39x), compared to the US market average (27.75x)

Valuation

ABT is poor value based on its earnings relative to its share price (59.39x), compared to the US Medical Devices industry average (55.45x)

Valuation

ABT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

6.32x

Industry

8.52x

Market

61.75x

ABT is good value based on its book value relative to its share price (6.32x), compared to the US market average (61.75x)

Valuation

ABT is good value based on its book value relative to its share price (6.32x), compared to the US Medical Devices industry average (8.52x)

Valuation

ABT price to earnings growth (PEG)

For valuing profitable companies with growth potential

ABT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.57x)

Valuation

ABT's financial health

Profit margin

Revenue

$8.9B

Net Income

$1.2B

Profit Margin

13.9%

ABT's Earnings (EBIT) of $4.41B can safely cover interest payments on company debt ($18.56B)

Financials

ABT's profit margin (10.5%) has not changed in the last year

Financials

Assets to liabilities

Assets

$69.0B

Liabilities

$37.4B

Debt to equity

0.59

ABT's short-term assets ($17.39B) exceed its short-term liabilities ($10.26B)

Financials

ABT's long-term liabilities ($27.19B) exceed its short-term assets ($17.39B)

Financials

ABT's debt has increased relative to shareholder equity (1.19), over the past 5 years ago (0.97)

Financials

ABT's debt to equity ratio (1.19) is considered high

Financials

Cash flow

Operating

$2.1B

Investing

-$472.0M

Financing

-$1.9B

ABT's operating cash flow ($6.52B) is sufficient to service the company's debt ($18.56B)

Financials

Abbott Laboratories Stock FAQ

What is Abbott Laboratories's quote symbol?

(NYSE: ABT) Abbott Laboratories trades on the NYSE under the ticker symbol ABT. Abbott Laboratories stock quotes can also be displayed as NYSE: ABT.

How much is Abbott Laboratories's stock price per share?

(NYSE: ABT) Abbott Laboratories stock price per share is $112.84 today (as of Jan 22, 2021).

What is the 52 week high and low for Abbott Laboratories (NYSE: ABT)?

(NYSE: ABT) Abbott Laboratories's 52-week high was $115.14, and its 52-week low was $61.61. It is currently -2% from its 52-week high and 83.15% from its 52-week low.

What is Abbott Laboratories's Market Cap?

(NYSE: ABT) Abbott Laboratories's market cap is $199.79B, as of Jan 23, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abbott Laboratories's market cap is calculated by multiplying ABT's current stock price of $112.84 by ABT's total outstanding shares of 1,770,529,999.

How much is Abbott Laboratories stock worth today?

(NYSE: ABT) Abbott Laboratories currently has 1,770,529,999 outstanding shares. With Abbott Laboratories stock trading at $112.84 per share, the total value of Abbott Laboratories stock (market capitalization) is $199.79B.

Abbott Laboratories stock was originally listed at a price of $32.75 in Dec 31, 1997. If you had invested in Abbott Laboratories stock at $32.75, your return over the last 23 years would have been 244.55%, for an annualized return of 5.53%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Zen Score

Reasons for this score

ABT News

Valuation

ABT price to earnings (PE)

For valuing profitable companies with steady earnings

ABT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

ABT price to earnings growth (PEG)

For valuing profitable companies with growth potential

ABT's financial health

Profit margin

Assets to liabilities

Cash flow

Abbott Laboratories Stock FAQ

(NYSE: ABT) Abbott Laboratories trades on the NYSE under the ticker symbol ABT. Abbott Laboratories stock quotes can also be displayed as NYSE: ABT.

(NYSE: ABT) Abbott Laboratories stock price per share is $112.84 today (as of Jan 22, 2021).

(NYSE: ABT) Abbott Laboratories's 52-week high was $115.14, and its 52-week low was $61.61. It is currently -2% from its 52-week high and 83.15% from its 52-week low.

Company

Stocks

Social